Collagen I antibody | NFI/20
Mutations in the encoding gene are associated with osteogenesis imperfecta (Peng et al. 2012), Ehlers Danlos syndrome (Nuytinck et al. 2000) and idiopathic juvenile osteoporosis (Pocock et al. 1995). Defective processing of collagen I by lysyl hydroxylase has also been implicated in Ehlers Danlos syndrome (Ihme et al. 1984),
- Target Species
- Product Form
- Ig fraction - lyophilised
- Use 1 ml of sterile distilled water.
- Ig fraction prepared by ammonium sulphate precipitation and DEAE-cellulose chromatography
- Preservative Stabilisers
- Contains mannitol, dextran & salts
- Human collagen type I from placenta.
- Prior to reconstitution store at +4oC.
After reconstitution store at -20oC.
Storage in frost-free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody.
- 12 months from date of reconstitution.
Applications of Collagen I antibody
|Application Name||Verified||Min Dilution||Max Dilution|
|Immunohistology - Frozen||1/20|
Secondary Antibodies Available
Product Specific References
References for Collagen I antibody
Zorin, V. et al. (2015) Clinical-instrumental and morphological evaluation of the effect of autologous dermal fibroblasts administration.
J Tissue Eng Regen Med. 11 (3): 778-86.
Zorin, V.L. et al. (2014) Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts.
Biomed Mater. 9 (5): 055005.
Seedhom, B.B. et al. (2007) In-situ engineering of cartilage repair: a pre-clinical in-vivo exploration of a novel system.
Proc Inst Mech Eng H. 221: 475-88.